Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain ( brain cell cultures / neonatal rats / nonpeptide receptor blockers / inositolphospholipid hydrolysis / cyclic GMP )
C. Sumners,Wei Tang,B. Železná,M. Raizada
Abstract:Both neurons and astrocytes contain specific receptors for angiotensin II (All). We used selective ligands for the AT, and AT2 types of All receptors to investigate the expression of functional receptor subtypes in astrocyte cultures and neuron cultures from 1-day-old (neonatal) rat brain. In astrocyte cultures, competition of 125I-labeled All (25I-AIl) specific binding with AT, (DuP753) or AT2 {PD123177, CGP42112A, [Phe(p-NH2)6]AII} selective receptor ligands revealed a potency series of All > DuP753 >>> CGP42112A > [Phe(p-NH2)6]AII > PD123177. These results suggest a predominance of the AT, receptor subtype in neonatal astrocytes. Also, in astrocyte cultures, All stimulated increases in inositolphospholipid hydrolysis that were significantly reduced by the AT1 receptor antagonist DuP753 but not altered by the AT2 receptor antagonist PD123177. In neonatal neuron cultures, competition of 125I-AII specific binding with the above ligands revealed a potency series of CGP42112A = All > [Phe(pNH2)6jAII > PD123177 >>> DuP753. 125I-AII specific binding to neonate neuronal cultures was reduced 73 84% by 1,M PD123177, and the residual 125I-AHl specific binding was eliminated by DuP753. Also, in neuron cultures, All induced decreases in basal cGMP that were completely blocked by PD123177 or CGP42112A but not by DuP753. Our results suggest that astrocyte cultures from neonatal rat brains contain predominantly AT1 receptors that are coupled to a stimulation of inositophospholipid hydrolysis. In contrast, neuron cultures from neonatal rat brain contain mostly AT2 receptors that are coupled to a reduction in basal cGMP levels, but a smaller population of AT1 receptors is also present in these neurons. Both neuron cultures and astrocyte cultures prepared from brains of 1-day-old (neonatal) rats contain specific binding sites for angiotensin II (All) (1-3). These binding sites appear to be functional receptors. For example, in neuron cultures, All causes a decrease in basal cGMP (3, 4) and stimulates catecholamine synthesis and metabolism (5, 6). In astrocyte cultures, All stimulates increased inositolphospholipid (IP) hydrolysis and also secretion of both plasminogen-activator inhibitor 1 and tissue metalloprotease inhibitor-related protein (2, 3, 7). All of these effects in cultured neurons or astrocytes are blocked by the All receptor antagonists saralasin and [Sar1,1le8]AII (Sar, sarcosine) (2-6). Two distinct subtypes of All receptor have been revealed by their differential affinities for nonpeptide drugs (DuP753, PD123177, WL-19) or peptides {CGP42112A, [Phe(pNH2)6]AII} (8-12). AT1 receptors (also designated AII-i, type B, or AIIc) have a high affinity for DuP753, and their density is reduced by sulfhydryl reducing agents (9, 10). AT1 receptors predominate in adrenal cortex, liver, vascular smooth muscle, and mesangial cells and are present in rat uterus and brain (8-14). This All receptor subtype is coupled to stimulation of IP hydrolysis (13, 14). AT2 receptors (also designated AII-2, type A, or AIIf3) have high affinities for PD123177, WL-19, CGP42112A, and [Phe(p-NH2)I]AII, and the affinity ofthis subtype is increased by sulfhydryl reducing agents (9, 10). AT2 receptors are present in adrenal medulla, rat and human uterus, PC12 rat pheochromocytoma cells, and in the brain (8, 10, 12), though as yet no intracellular effect mediated by these receptors has been identified. In the present study our aims were (i) to examine which subtype(s) of All receptors was present in neuron and astrocyte cultures from neonatal rat brain and (ii) to determine whether these receptors were functional in terms of mediating changes in intracellular messengers. Our results demonstrate that neonatal astrocytes contain predominantly AT1 receptors that are coupled to stimulation of IP hydrolysis. On the other hand, neonatal neurons contain mostly AT2 receptors that are coupled to a reduction in cGMP levels, but these neurons also contain a small population of AT1 sites. MATERIALS AND METHODS Materials. One-day-old Sprague-Dawley rats were obtained from our breeding colony, which originated from Charles River Breeding Laboratories. Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum were purchased from GIBCO. Plasma-derived horse serum was from HyClone. myo-[2-3Hfinositol (20 ,Ci/mmol; 1,Ci = 37 kBq) was from Amersham. 125I-labeled All (2200 Ci/mmol) and 125I-cGMP radioimmunoassay kits were from DuPont/NEN. All, polyethyleneimine, Na2EDTA, DL-dithiothreitol (DPTT), bacitracin, bovine serum albumin, and o-phenanthroline were from Sigma. [Phe(p-NH2)6]AII was from Bachem. All other biochemicals were purchased from Fisher. Preparation of Neuron and Astrocyte Cultures. Neuron and astrocyte cultures were prepared from the whole brains of 1-day-old rats exactly as detailed previously (3, 4). Neuron cultures were grown in DMEM/10% plasma-derived horse serum in either 35-mm (cGMP analyses) or 100-mm (125I-AII binding analyses) culture dishes for 10-15 days; such cultures consist ofapproximately 90% neurons and 10% astrocytes (3, 4). Astrocyte cultures were grown in DMEM/10% fetal bovine serum in either 35-mm (IP hydrolysis assays) or 100-mm (125I-AII binding analyses) dishes for 15-20 days; such cultures consist of >98% astrocytes (3, 4). Analysis of AII Specific Binding. All specific binding to membranes prepared from neuron or astrocyte cultures was assayed as follows, with 1251-AII as the radioactive ligand. Six Abbreviations: All, angiotensin II; DTT, dithiothreitol; IP, inositolphospholipid. *To whom reprint requests should be addressed at: Department of Physiology, Box J-274, University of Florida, Gainesville, FL 32610-0274. 7567 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 7568 Neurobiology: Sumners et al. 100-mm dishes of either neuron or astrocyte cultures were washed twice with phosphate-buffered saline (pH 7.4), and the cells were removed from the dishes with the aid of a rubber policeman. Cells from either neuronal or astrocyte cultures were pooled, pelleted by centrifugation (600 x g, 10 min), resuspended in 2.0 ml of buffer A (50 mM Tris-HCI/150 mM NaCl/5 mM Na2EDTA, pH 7.4 at 40C), and homogenized (Tekmar Tissuemizer, 10 sec at setting 40). Homogenates were centrifuged at 48,000 x g and 40C for 10 min, supernatants were discarded, and pellets were thoroughly resuspended in 3.0 ml of buffer A. An aliquot (10 ,p1) of the membrane suspension was taken for protein assay (15). In some experiments, membranes from neuron or astrocyte cultures were incubated with 5 mM DTT for 15 min prior to the binding assays. Binding assays were initiated by incubating 100 /.l (=200 pug of protein) of either neuron or astrocyte membranes with 400 Aul of buffer A containing 0.15 nM 1251-AII, 0.1% bovine serum albumin, 0.1% bacitracin, and 10 ,uM o-phenanthroline in a 12 x 75 mm polypropylene tube for 30 min at 24°C. For competition studies, unlabeled All or other drugs were included in the incubation mixture at 10 pM to 1 ,uM, and 1 ,uM All was added to a parallel set of tubes for analysis of nonspecific binding. Following the incubations, 3.0 ml of ice-cold buffer A was added to each tube, and membrane-bound radioactivity was separated from free radioactivity by filtration through Whatman GF/C filters (presoaked with 0.3% polyethyleneimine) under vacuum. Each filter was washed twice more with 3.0 ml of bufferA and placed in a glass test tube, and then radioactivity was estimated in a Beckman 5500 y counter (75% efficiency for 125i). 1251-AII specific binding was calculated as fmol/mg of protein. Analysis of IP Hydrolysis. IP hydrolysis was analyzed in control, All-, or drug-treated astrocyte cultures as described (16). Cultures were prelabeled with myo-[2-3H]inositol (1 p.Ci per dish) for 3 days prior to experiments to allow maximum incorporation of [3H]inositol into phospholipids. IP hydrolysis in control, All-, or drug-treated cultures is expressed as the total [3H]inositol phosphates released expressed as a percentage of the total [3H]inositol incorporated into the cultures. Extraction and Analysis of cGMP. Levels of cGMP in control, All-, or drug-treated neuron cultures were analyzed by radioimmunoassay exactly as detailed previously (4) and are expressed as pmol of cGMP per mg of protein. Experimental Groups and Data Analysis. For individual IP hydrolysis and cGMP experiments, each data point was obtained from four 35-mm dishes. For individual 125I-AII binding experiments in neuron or astrocyte membranes, six 100-mm dishes of either cell type were used per experiment. Multiple means were compared by analysis of variance (ANOVA-1) followed by a Newman-Keuls test, and differences at the 5% level were considered statistically significant.